Physician profile
Haresh Sampathkumar
NPI 1568803575
$28,791.26
in general payments reported to CMS, 2019-2025
17 companies · $315 in 2025
The $315 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $279 · 2021: $372 · 2022: $27K · 2023: $343 · 2024: $547 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,204.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainscope Company, INC. | $24,991.50 | 2022 | |
| Medtronic, INC. | $1,851.05 | 2021-2023 | Synchromedii |
| Medtronic USA, INC. | $518.78 | 2019-2020 | |
| Abbvie INC. | $500.94 | 2022-2025 | Botox, Ubrelvy, Qulipta |
| Microtransponder, INC. | $284.39 | 2023-2024 | |
| Allergan, INC. | $126.45 | 2020-2022 | |
| Pfizer INC. | $109.04 | 2024-2025 | |
| Penumbra, INC. | $108.55 | 2024 | Real Immersive System |
| Abbott Laboratories | $100.62 | 2024 | Octrode |
| Merz Pharmaceuticals, LLC | $48.44 | 2021-2023 | Xeomin |
| Indivior INC. | $28.95 | 2019-2020 | |
| Piramal Critical Care | $28.22 | 2022 | |
| Avanos Medical | $24.08 | 2019 | |
| Scilex Pharmaceuticals INC. | $21.05 | 2023 | Ztlido |
| Revance Therapeutics, INC. | $19.58 | 2024 | Daxxify |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $15.88 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $13.74 | 2023 | Nuedexta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haresh Sampathkumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.